94 related articles for article (PubMed ID: 2276894)
21. Effects of short-term supplementation with coenzyme Q10 on myocardial protection during cardiac operations.
Taggart DP; Jenkins M; Hooper J; Hadjinikolas L; Kemp M; Hue D; Bennett G
Ann Thorac Surg; 1996 Mar; 61(3):829-33. PubMed ID: 8619701
[TBL] [Abstract][Full Text] [Related]
22. Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates.
Cicero AF; Derosa G; Miconi A; Laghi L; Nascetti S; Gaddi A
Biomed Pharmacother; 2005 Jul; 59(6):312-7. PubMed ID: 15932792
[TBL] [Abstract][Full Text] [Related]
23. Research on coenzyme Q10 in clinical medicine and in immunomodulation.
Folkers K; Wolaniuk A
Drugs Exp Clin Res; 1985; 11(8):539-45. PubMed ID: 3836873
[TBL] [Abstract][Full Text] [Related]
24. Reduction in blood viscosity by treatment with coenzyme Q10 in patients with ischemic heart disease.
Kato T; Yoneda S; Kako T; Koketsu M; Hayano I; Fujinami T
Int J Clin Pharmacol Ther Toxicol; 1990 Mar; 28(3):123-6. PubMed ID: 2318549
[TBL] [Abstract][Full Text] [Related]
25. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases.
Lockwood K; Moesgaard S; Yamamoto T; Folkers K
Biochem Biophys Res Commun; 1995 Jul; 212(1):172-7. PubMed ID: 7612003
[TBL] [Abstract][Full Text] [Related]
26. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure.
Sander S; Coleman CI; Patel AA; Kluger J; White CM
J Card Fail; 2006 Aug; 12(6):464-72. PubMed ID: 16911914
[TBL] [Abstract][Full Text] [Related]
27. [The chronic effect of coenzyme Q10 in dilated cardiomyopathy: echocardiographic assessment].
Nakanishi M; Yokota Y; Fukuzaki H
Kokyu To Junkan; 1988 Jun; 36(6):655-60. PubMed ID: 3217604
[No Abstract] [Full Text] [Related]
28. A modified determination of coenzyme Q10 in human blood and CoQ10 blood levels in diverse patients with allergies.
Ye CQ; Folkers K; Tamagawa H; Pfeiffer C
Biofactors; 1988 Dec; 1(4):303-6. PubMed ID: 3255359
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of coenzyme Q10 in clinical cardiology: a long-term study.
Langsjoen H; Langsjoen P; Langsjoen P; Willis R; Folkers K
Mol Aspects Med; 1994; 15 Suppl():s165-75. PubMed ID: 7752828
[TBL] [Abstract][Full Text] [Related]
30. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
31. [Protective effect of CoQ 10 administration on cardial toxicity in FAC therapy].
Takimoto M; Sakurai T; Kodama K; Yokoi H; Suzuki Y; Enomoto K; Okada N
Gan To Kagaku Ryoho; 1982 Jan; 9(1):116-21. PubMed ID: 7184359
[TBL] [Abstract][Full Text] [Related]
32. Coenzyme Q10 and statins: biochemical and clinical implications.
Littarru GP; Langsjoen P
Mitochondrion; 2007 Jun; 7 Suppl():S168-74. PubMed ID: 17482884
[TBL] [Abstract][Full Text] [Related]
33. The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children.
Soongswang J; Sangtawesin C; Durongpisitkul K; Laohaprasitiporn D; Nana A; Punlee K; Kangkagate C
Pediatr Cardiol; 2005; 26(4):361-6. PubMed ID: 16374685
[TBL] [Abstract][Full Text] [Related]
34. Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression.
Rusciani L; Proietti I; Rusciani A; Paradisi A; Sbordoni G; Alfano C; Panunzi S; De Gaetano A; Lippa S
J Am Acad Dermatol; 2006 Feb; 54(2):234-41. PubMed ID: 16443053
[TBL] [Abstract][Full Text] [Related]
35. A pilot clinical trial of the effects of coenzyme Q10 on chronic tinnitus aurium.
Khan M; Gross J; Haupt H; Jainz A; Niklowitz P; Scherer H; Schmidt FP; Klapp BF; Reisshauer A; Mazurek B
Otolaryngol Head Neck Surg; 2007 Jan; 136(1):72-7. PubMed ID: 17210337
[TBL] [Abstract][Full Text] [Related]
36. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10.
Langsjoen PH; Vadhanavikit S; Folkers K
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4240-4. PubMed ID: 3858877
[TBL] [Abstract][Full Text] [Related]
37. A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS.
Levy G; Kaufmann P; Buchsbaum R; Montes J; Barsdorf A; Arbing R; Battista V; Zhou X; Mitsumoto H; Levin B; Thompson JL
Neurology; 2006 Mar; 66(5):660-3. PubMed ID: 16534103
[TBL] [Abstract][Full Text] [Related]
38. Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10.
Cortes EP; Gupta M; Chou C; Amin VC; Folkers K
Cancer Treat Rep; 1978 Jun; 62(6):887-91. PubMed ID: 667863
[TBL] [Abstract][Full Text] [Related]
39. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy.
Molhoek SG; Bax JJ; van Erven L; Bootsma M; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
Am J Cardiol; 2004 Apr; 93(7):860-3. PubMed ID: 15050489
[TBL] [Abstract][Full Text] [Related]
40. Coenzyme Q10 combined with mild hypothermia after cardiac arrest: a preliminary study.
Damian MS; Ellenberg D; Gildemeister R; Lauermann J; Simonis G; Sauter W; Georgi C
Circulation; 2004 Nov; 110(19):3011-6. PubMed ID: 15520321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
